BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 38188026)

  • 1. New insight on microglia activation in neurodegenerative diseases and therapeutics.
    Xu Y; Gao W; Sun Y; Wu M
    Front Neurosci; 2023; 17():1308345. PubMed ID: 38188026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of circadian clocks in neurodegenerative diseases.
    Chang YC; Kim JY
    J Neurosci Res; 2020 Jun; 98(6):1095-1113. PubMed ID: 31833091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases.
    Russo C; Valle MS; Russo A; Malaguarnera L
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Osteopontin on Microglia.
    Yu H; Liu X; Zhong Y
    Biomed Res Int; 2017; 2017():1879437. PubMed ID: 28698867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases.
    Cheng WY; Ho YS; Chang RC
    Ageing Res Rev; 2022 Jun; 78():101620. PubMed ID: 35405323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
    Pey P; Pearce RK; Kalaitzakis ME; Griffin WS; Gentleman SM
    Acta Neuropathol Commun; 2014 Feb; 2():21. PubMed ID: 24528486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian disruption and sleep disorders in neurodegeneration.
    Shen Y; Lv QK; Xie WY; Gong SY; Zhuang S; Liu JY; Mao CJ; Liu CF
    Transl Neurodegener; 2023 Feb; 12(1):8. PubMed ID: 36782262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Microglia in Neurodegenerative Diseases.
    Nakaso K
    Yonago Acta Med; 2024 Feb; 67(1):1-8. PubMed ID: 38380436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles: A Hope for the Treatment of Inflammation in CNS.
    Zhu FD; Hu YJ; Yu L; Zhou XG; Wu JM; Tang Y; Qin DL; Fan QZ; Wu AG
    Front Pharmacol; 2021; 12():683935. PubMed ID: 34122112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging Microglia-Phenotypes, Functions and Implications for Age-Related Neurodegenerative Diseases.
    Spittau B
    Front Aging Neurosci; 2017; 9():194. PubMed ID: 28659790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting innate immunity for neurodegenerative disorders of the central nervous system.
    Andreasson KI; Bachstetter AD; Colonna M; Ginhoux F; Holmes C; Lamb B; Landreth G; Lee DC; Low D; Lynch MA; Monsonego A; O'Banion MK; Pekny M; Puschmann T; Russek-Blum N; Sandusky LA; Selenica ML; Takata K; Teeling J; Town T; Van Eldik LJ
    J Neurochem; 2016 Sep; 138(5):653-93. PubMed ID: 27248001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
    Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia Phenotypes in Aging and Neurodegenerative Diseases.
    Wendimu MY; Hooks SB
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
    Peña-Altamira E; Prati F; Massenzio F; Virgili M; Contestabile A; Bolognesi ML; Monti B
    Expert Opin Ther Targets; 2016; 20(5):627-40. PubMed ID: 26568363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion channels on microglia: therapeutic targets for neuroprotection.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
    Giunti D; Parodi B; Cordano C; Uccelli A; Kerlero de Rosbo N
    Immunology; 2014 Mar; 141(3):328-39. PubMed ID: 24116890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Microglia in the Development of Neurodegenerative Diseases.
    Lee JW; Chun W; Lee HJ; Kim SM; Min JH; Kim DY; Kim MO; Ryu HW; Lee SU
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial activation and its implications in the brain diseases.
    Dheen ST; Kaur C; Ling EA
    Curr Med Chem; 2007; 14(11):1189-97. PubMed ID: 17504139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases.
    Sandhu JK; Kulka M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
    Kwon HS; Koh SH
    Transl Neurodegener; 2020 Nov; 9(1):42. PubMed ID: 33239064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.